Clinical Trial Update: Demonstrate Exubera Works As Well As Avandia When Added To Sulfonylurea + Metformin In Controlling Glucose [Phase 3]

View source ↗

Summary

Phase 3 trial shows inhaled insulin Exubera provides glucose control comparable to rosiglitazone (Avandia) when added to sulfonylurea plus metformin in diabetes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Avandia (rosiglitazone)
• Exubera (insulin inhalation powder)

Snippet

Sponsor: Pfizer | Conditions: Diabetes Mellitus | Phase 3 | Status: COMPLETED